UAE Viscosupplementation Market Size & Outlook, 2023-2030
UAE viscosupplementation market, 2018-2030 (US$M)
Related Markets
UAE viscosupplementation market highlights
- The UAE viscosupplementation market generated a revenue of USD 2.1 million in 2023 and is expected to reach USD 4.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 2.1 million |
| Market revenue in 2030 | USD 4.0 million |
| Growth rate | 9.7% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5.2 million by 2030.
Single injection was the largest segment with a revenue share of 42.86% in 2023. Horizon Databook has segmented the UAE viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of osteoarthritis in the UAE has increased over the past years, especially among the elderly, because of age-related changes in the joint. There are no such statistics available for UAE, but numbers from the Gulf region suggest that the prevalence of osteoarthritis is 20%-25% in the country.
From several studies, it has been found that in the country, among the population and geriatric population 60 year and above, around 25% of people significant suffers from pain and disability caused by osteoarthritis. This is also called degenerative arthritis which affects the joints of the spine, feet, and hands, hips and knees.
Bodies like the Emirates Physiotherapy Society (EPS), and Orthopedic Medical Therapy Group (OMTG), are working towards the wellness of the patients suffering from osteoarthritis by offering various exercise and conducting wellness programs.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE viscosupplementation market size, by product, 2018-2030 (US$M)
UAE Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
